Short-acting insulin and carbohydrate intake
HYPERGLYCAEMIA, EVENT, HYPOGLYCAEMIA
The evening after the exercise test, three people (17%) in CON, one (6%) in D40 and one (6%) in D20-P injected additional short-acting insulin because of profound hyperglycaemia. During this evening, nine people (50%) in CON, five (28%) in D40 and two (11%) in D20-P ingested additional carbohydrates to prevent hypoglycaemia. However, of these participants, only one within each treatment arm ingested carbohydrates after 23:00 hours without experiencing a nocturnal hypoglycaemic event. No differences were found in the total daily dose of short-acting insulin used between the treatment regimens on the first and second days after the exercise test (ESM Fig. 